Jonathan Medved, CEO of the Jerusalem-based global investment platform OurCrowd, told The Media Line that the outbreak had shifted the focus of many investors in a way that could have far-reaching implications for medical innovation.
Read more here.
Comments
Source: https://blog.ourcrowd.com/expect-a-renaissance-in-medical-innovation-says-ourcrowd-chief-2/
